(MedPage Today) — Treatment with the antiviral oseltamivir (Tamiflu) was tied to a reduced risk of serious neuropsychiatric events in children and adolescents, an analysis of Medicaid beneficiaries in Tennessee suggested.
Compared with untreated…
Source link : https://www.medpagetoday.com/neurology/generalneurology/116827
Author :
Publish date : 2025-08-04 21:32:00
Copyright for syndicated content belongs to the linked Source.
